ORASURE TECHNOLOGIES INC. - COMMON STOCK

InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

17 май 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue

10 май 2022 16:05:01 Источник Nasdaq GlobeNewswire

OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET

03 май 2022 16:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples

07 апр 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples

31 мар 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role

22 мар 2022 16:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up

23 фев 2022 16:05:01 Источник Nasdaq GlobeNewswire

OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ET

16 фев 2022 16:05:01 Источник Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App

31 янв 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe

25 янв 2022 07:05:00 Источник Nasdaq GlobeNewswire

InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants

13 янв 2022 16:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Announces Actions to Enhance Stockholder Value

05 янв 2022 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Announces 2022 Annual Meeting Date

14 дек 2021 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus

30 ноя 2021 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies to Present at Upcoming Investor Conferences

19 ноя 2021 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary

09 ноя 2021 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Appoints Two New Members to the Board of Directors

08 ноя 2021 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22

03 ноя 2021 16:05:02 Источник Nasdaq GlobeNewswire

U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection

02 ноя 2021 07:05:00 Источник Nasdaq GlobeNewswire

OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5:00 p.m. ET

27 окт 2021 07:05:00 Источник Nasdaq GlobeNewswire